General Information of Drug Transporter (DT)
DT ID DTD0368 Transporter Info
Gene Name SLC45A1
Transporter Name Proton-associated sugar transporter A
Gene ID
50651
UniProt ID
Q9Y2W3
Post-Translational Modification of This DT
Overview of SLC45A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

478

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC45A1 Lysine 478 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A1 [2]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

486

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC45A1 Lysine 486 has the potential to affect its expression or activity.

Phosphorylation

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

649

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Glycine 649 has the potential to affect its expression or activity.

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

628

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Leucine 628 has the potential to affect its expression or activity.

  Serine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

40

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 40 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A1 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

41

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 41 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC45A1 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

384

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 384 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC45A1 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

387

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 387 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC45A1 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

473

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 473 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC45A1 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

477

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 477 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC45A1 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

481

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 481 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC45A1 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

482

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Serine 482 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

42

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Threonine 42 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A1 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

476

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Threonine 476 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

662

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Tyrosine 662 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A1 [3] , [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

671

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Tyrosine 671 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC45A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

683

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Tyrosine 683 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [3] , [11]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

637

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC45A1 Valine 637 has the potential to affect its expression or activity.

Ubiquitination

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [12]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

455

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC45A1 Glycine 455 has the potential to affect its expression or activity.

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [12]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

486

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC45A1 Lysine 486 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC45A1 [12]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

525

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC45A1 Lysine 525 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC45A1 [12]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

494

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC45A1 Proline 494 has the potential to affect its expression or activity.
References
1 XRCC1 Arg194Trp polymorphism and risk of chronic obstructive pulmonary disease. J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):551-6.
2 Fabrication of a novel hybrid scaffold for tissue engineered heart valve. J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):599-603.
3 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
5 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
6 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
7 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
9 Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
10 Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
11 Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
12 Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.